Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
Oportun Financial
OPRT
$404M
| $359K | ﹤0.01% |
77,797
+28,022
| +56% | +$143K |
2025 Q4
1 quarter
|
|
2077
Akebia Therapeutics
AKBA
$195M
| $358K | ﹤0.01% |
257,854
+49,259
| +24% | +$67.7K |
2025 Q2
3 quarters
|
|
2078
Kimco Realty
KIM
$15B
| $358K | ﹤0.01% |
15,943
-178,002
| -92% | -$3.92M |
2024 Q4
5 quarters
|
|
2079
Morningstar
MORN
$7.65B
| $355K | ﹤0.01% |
2,100
-7,436
| -78% | -$1.38M |
2023 Q4
9 quarters
|
|
2080
HNI Corp
HNI
$3.35B
| $355K | ﹤0.01% |
10,619
-4,314
| -29% | -$191K |
2025 Q3
2 quarters
|
|
2081
Rubrik
RBRK
$23.6B
| $354K | ﹤0.01% |
7,224
-206,927
| -97% | -$11.9M |
2025 Q1
4 quarters
|
|
2082
Fulcrum Therapeutics
FULC
$280M
| $354K | ﹤0.01% |
46,119
+30,866
| +202% | +$286K |
2025 Q4
1 quarter
|
|
2083
Knife River
KNF
$2.72B
| $354K | ﹤0.01% |
4,330
-4,025
| -48% | -$324K |
2024 Q2
7 quarters
|
|
2084
Kelly Services Class A
KELYA
$548M
| $354K | ﹤0.01% |
39,945
+15,911
| +66% | +$152K |
2025 Q1
4 quarters
|
|
2085
Amneal Pharmaceuticals
AMRX
$6.58B
| $352K | ﹤0.01% |
28,358
-34,468
| -55% | -$463K |
2024 Q3
6 quarters
|
|
2086
Usana Health Sciences
USNA
$282M
| $352K | ﹤0.01% |
+20,171
| New | +$400K |
2026 Q1
0 quarters
|
|
2087
Flutter Entertainment
FLUT
$12.9B
| $351K | ﹤0.01% |
3,442
-82,749
| -96% | -$11.9M |
2024 Q3
6 quarters
|
|
2088
Rhythm Pharmaceuticals
RYTM
$5.97B
| $350K | ﹤0.01% |
4,022
-5,536
| -58% | -$538K |
2025 Q3
2 quarters
|
|
2089
International Bancshares
IBOC
$4.18B
| $347K | ﹤0.01% |
5,164
| – | – |
2025 Q4
1 quarter
|
|
2090
Everspin Technologies
MRAM
$333M
| $343K | ﹤0.01% |
+39,012
| New | +$429K |
2026 Q1
0 quarters
|
|
2091
Cooper Companies
COO
$10.4B
| $343K | ﹤0.01% |
4,794
-159,255
| -97% | -$12.6M |
2024 Q2
7 quarters
|
|
2092
Bio-Techne
TECH
$11.4B
| $342K | ﹤0.01% |
+6,540
| New | +$393K |
2026 Q1
0 quarters
|
|
2093
Atlas Energy Solutions
AESI
$1.38B
| $342K | ﹤0.01% |
+26,044
| New | +$304K |
2026 Q1
0 quarters
|
|
2094
Piedmont Realty Trust
PDM
$1.1B
| $339K | ﹤0.01% |
+51,659
| New | +$402K |
2026 Q1
0 quarters
|
|
2095
PCB Bancorp
PCB
$388M
| $338K | ﹤0.01% |
15,014
+2,995
| +25% | +$66.9K |
2025 Q4
1 quarter
|
|
2096
Phathom Pharmaceuticals
PHAT
$599M
| $337K | ﹤0.01% |
+30,352
| New | +$383K |
2026 Q1
0 quarters
|
|
2097
Gray Television
GTN
$446M
| $336K | ﹤0.01% |
+77,463
| New | +$364K |
2026 Q1
0 quarters
|
|
2098
Ceco Environmental
CECO
$3.65B
| $335K | ﹤0.01% |
+5,628
| New | +$362K |
2026 Q1
0 quarters
|
|
2099
Vital Farms
VITL
$383M
| $335K | ﹤0.01% |
23,701
+16,654
| +236% | +$394K |
2023 Q3
10 quarters
|
|
2100
CALL
Philip Morris
PM
$320B
| $331K | ﹤0.01% |
+2,000
| New | +$348K |
2026 Q1
0 quarters
|
|
Similar funds
NC
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.